ID
16921
Description
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00220155
Link
https://clinicaltrials.gov/show/NCT00220155
Keywords
Versions (1)
- 8/14/16 8/14/16 -
Uploaded on
August 14, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Colorectal Cancer NCT00220155
Eligibility Colorectal Cancer NCT00220155
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
medical or psychiatric condition that comprise the patient's ability to take informed consent.
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
- UMLS CUI [2]
- C0004936
- UMLS CUI [3]
- C0021430
Description
chemotherapy or radiotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
Description
gemcitabine
Data type
boolean
Alias
- UMLS CUI [1]
- C0045093
Description
uncontrolled cerebral metastases
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0205318
Similar models
Eligibility Colorectal Cancer NCT00220155
- StudyEvent: Eligibility
C1319315 (UMLS CUI [1,2])
C0677984 (UMLS CUI [1,2])
C0009402 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C1514457 (UMLS CUI [3])
C0040405 (UMLS CUI [1,2])
C0518015 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
C0023508 (UMLS CUI [4])
C0200633 (UMLS CUI [5])
C0205318 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
C1522449 (UMLS CUI [2])
C0205318 (UMLS CUI [1,2])